Stock listing

Hemostemix Inc

Selected listing: 2VF0 · TRADEGATE · EUR · DE

Hemostemix Inc (Tradegate:2VF0), Health Technology. Latest release Sep 28, 2026: Hemostemix to Attend Centurion One Capital's 4th Annual Bahamas Summit.

2VF0:TRADEGATEEURDEUpdated October 2, 2026

Ticker: Tradegate:2VF0
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Tradegate
Currency: EUR

About Hemostemix Inc

The company focuses on developing innovative therapies in the field of regenerative medicine. Hemostemix aims to address unmet medical needs through its research and development efforts.

Latest news from Hemostemix Inc

Hemostemix to Attend Centurion One Capital's 4th Annual Bahamas Summit

September 28, 2026

Hemostemix Non Brokered Private Placement

September 23, 2026

Hemostemix Commercializes Its Vascular Dementia Clinical Trial of VesCell(TM) Under LARTA

August 20, 2026

Dr. Ernst von Schwarz, Principal Investigator of Hemostemix VesCell(TM) Longevity Clinical Trial

August 12, 2026

Hemostemix Closes Second Tranche of Private Placement and Obtains Extension to August 14, 2026

July 30, 2026

All Hemostemix Inc news →

Research Hemostemix Inc

Hemostemix Inc company profile

View the public company page for Hemostemix Inc on 6ix.

Hemostemix Inc news

Read company news and market updates connected to Hemostemix Inc.

Hemostemix Inc investor events

Find investor webinars, events, and replay context for Hemostemix Inc.